VANCOUVER, British Columbia, Jan. 19, 2021 (GLOBE NEWSWIRE) — New Leaf Ventures Inc. (CSE: NLV) (OTC: NLVVF) (“New Leaf,” “NLV” or the “Company”), a management and investment organization dedicated to evaluating, investing and accelerating advanced stage operations in the North American Cannabis sector is pleased to announce its New Leaf USA venture with brand license operator New Leaf Enterprises reported overall incremental growth associated with unexpected upward market trends predicted to continue throughout 2021.
Robert (Dax) Colwell, CEO of New Leaf USA & Director at New Leaf Ventures Inc. notes, “The onset of COVID-19 created a great deal of initial uncertainty which resulted in a lessening of momentum across the sector. Since 2020 was a transformative year for New Leaf with new sources of capital and governance combined with a number of infrastructural investments, we had anticipated a period of contracted earnings as a result. However, as the year progressed it soon became apparent that the pandemic was shaping a different story that introduced an unexpected and previously untapped demand for cannabis, and by the end of the year had grown into a sense of commercial optimism which we expect to see continue well into 2021.”
Recent upgrades to the licensed facility look to positively impact projected revenues for 2021. Equipment improvements to the cultivation rooms and greenhouse such as advanced dehumidification systems and LED lighting offer improved yield and revenue potential while simultaneously decreasing operational costs. Through these fundamental improvements a 25% increase in crop yield has been achieved. Perhaps more importantly, the upgrades resulted in a quantifiable quality increase resulting in a 25% price increase aligning the DAMA Premium brand with competitive products.
As part of the company’s planned entry into the rapidly growing infused beverage market, the strategic partnership with Schilling Hard Cider is reaching Phase 2 in the development process of the infused beverage line of products. Market testing and flavor development are continuing along with the build out of the Company’s new 7000 sq. ft. commercial kitchen.
Concurrently, negotiations for a definitive agreement to acquire Zen Asset Management LLC and its parent company, Artizen Asset Management LLC are ongoing and expected to be completed by Q1. This move would strengthen the portfolio by scaling market share in Washington State to access biomass inventory from 180,000 square feet of canopy.
Additional cause for optimism is strengthened by the recent launch and growing sales orders for the ‘Goodies’ edible product line which will deliver an entirely new and expanded revenue stream for the operation. Edible products are considered the fastest growing sector of the industry with broad adoption by users looking for alternative forms of consumption.
Michael Stier, CEO of New Leaf Ventures states, “It’s been a rocky year, but an even playing field for the industry as we were all forced to adapt to the new reality. I am grateful our investment timing allowed us to lead a period of corporate and structural re-organization during this period as we by necessity had to intensify our focus on our strategy and goals. From this experience we are stronger, and our ability to support scalability in both sales and production are huge value drivers for continued growth and long-term success for this exciting venture. As we look ahead, we are very excited and focused on our partnership with Schilling Hard Cider and solidifying our transaction with ZAM and Artizen.”
About New Leaf Ventures Inc. (CSE: NLV) (OTC: NLVVF)
New Leaf Ventures Inc. is developing a cannabis sector-based scalable securities concept of focused financing and applied management to achieve earnings growth through targeted investment. The Company’s flagship enterprise is New Leaf USA and its subsidiaries, which provide licenses, consulting services, real property, intellectual property and equipment for lease and ancillary services to a Washington-based Tier 3 Producer/Processor focused on cultivating, growing, processing, packaging, and distributing cannabis and cannabis related products. Find out more at: https://newleafventuresinc.com/.
For further information, please contact:
New Leaf Ventures Inc.
Invictus Investor Relations
Tel: +1 (604) 330-9220
Email: investors@newleafventuresinc.com
Forward Looking Statement
This news release contains statements and information that, to the extent that they are not historical fact, may constitute “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as “may”, “would”, “could”, “will”, “likely”, “except”, “anticipate”, “believe”, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook”, or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the objectives and business plans of the Company; ability to realize benefits from its recent corporate appointments; ability to retain its key personnel; the intention to grow the Company’s business and operations; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company.
Forward-looking information is based on the assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; and the Company’s ability to secure financing on reasonable terms.
Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all, as well as all of the other risks as described in the Company’s management discussion and analysis for year ended December 31, 2019 under the heading “Risks and Uncertainties”. Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.
The CSE does not accept responsibility for the adequacy or accuracy of this release.
Toronto, Ontario--(Newsfile Corp. - July 1, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the…
Conference Call Scheduled for Tuesday, July 2 at 11:30 AM EDTNorthvale, New Jersey--(Newsfile Corp. -…
SAN ANTONIO, July 1, 2024 /PRNewswire/ -- Replicare, a leading innovator in remote surgical telepresence…
MIAMI, July 1, 2024 /PRNewswire/ -- Med-Lab is excited to announce that it is changing…
ATLANTA, July 1, 2024 /PRNewswire/ -- SysInformation Healthcare Services, LLC ("SysInformation"), d/b/a EqualizeRCM, is a professional…
Openda: Empowering Healthcare Innovation with Advanced Medical Imaging Data Solutions PALO ALTO, Calif., July 1,…